Alvotech (ALVO)

NASDAQ: ALVO · Real-Time Price · USD

3.635

+0.025 (0.69%)

Apr 20, 2026, 3:13 PM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology	93.38M	85.02M	39.68M
Biotechnology Growth	9.84%	114.23%	-42.86%
Total	93.38M	85.02M	39.68M
Total Growth	9.84%	114.23%	-42.86%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Europe	307.22M	157.59M	63.51M	39.43M	20.51M
Europe Growth	94.95%	148.13%	61.06%	92.27%	4.05%
Usa	241.37M	273.04M	9.43M	17.94M	-
Usa Growth	-11.60%	2795.40%	-47.44%	-	-
Other Geographies	37.73M	59.06M	18.49M	25.66M	-
Other Geographies Growth	-36.11%	219.34%	-27.92%	-	-
North America	-	-	-	-	11.66M
North America Growth	-	-	-	-	-69.26%
Asia and Other	-	-	-	-	4.60M
Total	586.32M	489.68M	91.43M	83.03M	36.77M
Total Growth	19.74%	435.56%	10.12%	125.79%	-44.80%

Source: S&P Global Market Intelligence.